Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan
The coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines may offer a potential eradication of COVID-19. This study evaluated the general knowledge, attitude, and perception of COVID-19 vaccines in the Pakistan...
Saved in:
Published in: | PloS one Vol. 17; no. 3; p. e0266028 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Public Library of Science
24-03-2022
Public Library of Science (PLoS) |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines may offer a potential eradication of COVID-19. This study evaluated the general knowledge, attitude, and perception of COVID-19 vaccines in the Pakistani population.
A self-reporting e-survey and questionnaire-based survey from vaccination centers of different cities of Pakistan among 502 participants were conducted. The questionnaire comprised four sections inquiring demographics, vaccination status, and perception or attitude towards the vaccine. Univariate logistic regression was applied to predict the knowledge, attitude and behavior of participants.
The mean age of participants was 50.8±20.3 years. 53% of the participants have both doses of vaccine administered. Pain on the site of injection (49.8%) was the most common symptom, followed by asthenia (43.0%), muscle pain (29.5%), and swelling (24.5%) on the site of vaccine administration. Females complain of more symptoms than males. More severe symptoms were reported after the first dose of vaccine administration; these symptoms subsided within a week for most participants. Overall, the respondents have a positive attitude towards the vaccine. 47.4% are sure about the vaccine's efficacy, 48.6% said getting vaccinated was their own decision, and 79.9% also recommended others to get vaccinated.
The study concluded that the Pakistani population has a positive attitude but inadequate knowledge towards COVID-19 vaccines. Immediate awareness and vaccination education programs should be conducted by the authorities to complete the mass vaccination schedule. |
---|---|
AbstractList | BackgroundThe coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines may offer a potential eradication of COVID-19. This study evaluated the general knowledge, attitude, and perception of COVID-19 vaccines in the Pakistani population.MethodsA self-reporting e-survey and questionnaire-based survey from vaccination centers of different cities of Pakistan among 502 participants were conducted. The questionnaire comprised four sections inquiring demographics, vaccination status, and perception or attitude towards the vaccine. Univariate logistic regression was applied to predict the knowledge, attitude and behavior of participants.ResultsThe mean age of participants was 50.8±20.3 years. 53% of the participants have both doses of vaccine administered. Pain on the site of injection (49.8%) was the most common symptom, followed by asthenia (43.0%), muscle pain (29.5%), and swelling (24.5%) on the site of vaccine administration. Females complain of more symptoms than males. More severe symptoms were reported after the first dose of vaccine administration; these symptoms subsided within a week for most participants. Overall, the respondents have a positive attitude towards the vaccine. 47.4% are sure about the vaccine's efficacy, 48.6% said getting vaccinated was their own decision, and 79.9% also recommended others to get vaccinated.ConclusionThe study concluded that the Pakistani population has a positive attitude but inadequate knowledge towards COVID-19 vaccines. Immediate awareness and vaccination education programs should be conducted by the authorities to complete the mass vaccination schedule. The coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines may offer a potential eradication of COVID-19. This study evaluated the general knowledge, attitude, and perception of COVID-19 vaccines in the Pakistani population. A self-reporting e-survey and questionnaire-based survey from vaccination centers of different cities of Pakistan among 502 participants were conducted. The questionnaire comprised four sections inquiring demographics, vaccination status, and perception or attitude towards the vaccine. Univariate logistic regression was applied to predict the knowledge, attitude and behavior of participants. The mean age of participants was 50.8±20.3 years. 53% of the participants have both doses of vaccine administered. Pain on the site of injection (49.8%) was the most common symptom, followed by asthenia (43.0%), muscle pain (29.5%), and swelling (24.5%) on the site of vaccine administration. Females complain of more symptoms than males. More severe symptoms were reported after the first dose of vaccine administration; these symptoms subsided within a week for most participants. Overall, the respondents have a positive attitude towards the vaccine. 47.4% are sure about the vaccine's efficacy, 48.6% said getting vaccinated was their own decision, and 79.9% also recommended others to get vaccinated. The study concluded that the Pakistani population has a positive attitude but inadequate knowledge towards COVID-19 vaccines. Immediate awareness and vaccination education programs should be conducted by the authorities to complete the mass vaccination schedule. Background The coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines may offer a potential eradication of COVID-19. This study evaluated the general knowledge, attitude, and perception of COVID-19 vaccines in the Pakistani population. Methods A self-reporting e-survey and questionnaire-based survey from vaccination centers of different cities of Pakistan among 502 participants were conducted. The questionnaire comprised four sections inquiring demographics, vaccination status, and perception or attitude towards the vaccine. Univariate logistic regression was applied to predict the knowledge, attitude and behavior of participants. Results The mean age of participants was 50.8±20.3 years. 53% of the participants have both doses of vaccine administered. Pain on the site of injection (49.8%) was the most common symptom, followed by asthenia (43.0%), muscle pain (29.5%), and swelling (24.5%) on the site of vaccine administration. Females complain of more symptoms than males. More severe symptoms were reported after the first dose of vaccine administration; these symptoms subsided within a week for most participants. Overall, the respondents have a positive attitude towards the vaccine. 47.4% are sure about the vaccine’s efficacy, 48.6% said getting vaccinated was their own decision, and 79.9% also recommended others to get vaccinated. Conclusion The study concluded that the Pakistani population has a positive attitude but inadequate knowledge towards COVID-19 vaccines. Immediate awareness and vaccination education programs should be conducted by the authorities to complete the mass vaccination schedule. Background The coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines may offer a potential eradication of COVID-19. This study evaluated the general knowledge, attitude, and perception of COVID-19 vaccines in the Pakistani population. Methods A self-reporting e-survey and questionnaire-based survey from vaccination centers of different cities of Pakistan among 502 participants were conducted. The questionnaire comprised four sections inquiring demographics, vaccination status, and perception or attitude towards the vaccine. Univariate logistic regression was applied to predict the knowledge, attitude and behavior of participants. Results The mean age of participants was 50.8±20.3 years. 53% of the participants have both doses of vaccine administered. Pain on the site of injection (49.8%) was the most common symptom, followed by asthenia (43.0%), muscle pain (29.5%), and swelling (24.5%) on the site of vaccine administration. Females complain of more symptoms than males. More severe symptoms were reported after the first dose of vaccine administration; these symptoms subsided within a week for most participants. Overall, the respondents have a positive attitude towards the vaccine. 47.4% are sure about the vaccine’s efficacy, 48.6% said getting vaccinated was their own decision, and 79.9% also recommended others to get vaccinated. Conclusion The study concluded that the Pakistani population has a positive attitude but inadequate knowledge towards COVID-19 vaccines. Immediate awareness and vaccination education programs should be conducted by the authorities to complete the mass vaccination schedule. The coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines may offer a potential eradication of COVID-19. This study evaluated the general knowledge, attitude, and perception of COVID-19 vaccines in the Pakistani population. A self-reporting e-survey and questionnaire-based survey from vaccination centers of different cities of Pakistan among 502 participants were conducted. The questionnaire comprised four sections inquiring demographics, vaccination status, and perception or attitude towards the vaccine. Univariate logistic regression was applied to predict the knowledge, attitude and behavior of participants. The mean age of participants was 50.8±20.3 years. 53% of the participants have both doses of vaccine administered. Pain on the site of injection (49.8%) was the most common symptom, followed by asthenia (43.0%), muscle pain (29.5%), and swelling (24.5%) on the site of vaccine administration. Females complain of more symptoms than males. More severe symptoms were reported after the first dose of vaccine administration; these symptoms subsided within a week for most participants. Overall, the respondents have a positive attitude towards the vaccine. 47.4% are sure about the vaccine's efficacy, 48.6% said getting vaccinated was their own decision, and 79.9% also recommended others to get vaccinated. The study concluded that the Pakistani population has a positive attitude but inadequate knowledge towards COVID-19 vaccines. Immediate awareness and vaccination education programs should be conducted by the authorities to complete the mass vaccination schedule. |
Audience | Academic |
Author | Rasheed, Muhammad Adil Majeed, Arfa Shoaib, Qurat-Ul-Ain Ahmad, Muhammad Moin Aroosa, Sadaf Beg, Bilal Mahmood Areej, Sadaf Hussain, Tariq Ahmad, Mehmood |
AuthorAffiliation | 2 Department of Basic Sciences, College of Veterinary and Animal Science Jhang, Jhang, Pakistan 5 Department of Pharmaceutics, Akhtar Saeed College of Pharmaceutical Science Lahore, Lahore, Pakistan 1 Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences Lahore, Lahore, Pakistan The University of Mississippi Medical Center, UNITED STATES 4 Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway 3 Department of Pharmacology, Riphah International University Lahore, Lahore, Pakistan |
AuthorAffiliation_xml | – name: 2 Department of Basic Sciences, College of Veterinary and Animal Science Jhang, Jhang, Pakistan – name: The University of Mississippi Medical Center, UNITED STATES – name: 1 Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences Lahore, Lahore, Pakistan – name: 3 Department of Pharmacology, Riphah International University Lahore, Lahore, Pakistan – name: 4 Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway – name: 5 Department of Pharmaceutics, Akhtar Saeed College of Pharmaceutical Science Lahore, Lahore, Pakistan |
Author_xml | – sequence: 1 givenname: Bilal Mahmood orcidid: 0000-0001-6797-4879 surname: Beg fullname: Beg, Bilal Mahmood organization: Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences Lahore, Lahore, Pakistan – sequence: 2 givenname: Tariq surname: Hussain fullname: Hussain, Tariq organization: Department of Basic Sciences, College of Veterinary and Animal Science Jhang, Jhang, Pakistan – sequence: 3 givenname: Mehmood surname: Ahmad fullname: Ahmad, Mehmood organization: Department of Pharmacology, Riphah International University Lahore, Lahore, Pakistan – sequence: 4 givenname: Sadaf surname: Areej fullname: Areej, Sadaf organization: Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences Lahore, Lahore, Pakistan – sequence: 5 givenname: Arfa surname: Majeed fullname: Majeed, Arfa organization: Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences Lahore, Lahore, Pakistan – sequence: 6 givenname: Muhammad Adil surname: Rasheed fullname: Rasheed, Muhammad Adil organization: Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences Lahore, Lahore, Pakistan – sequence: 7 givenname: Muhammad Moin surname: Ahmad fullname: Ahmad, Muhammad Moin organization: Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway – sequence: 8 givenname: Qurat-Ul-Ain surname: Shoaib fullname: Shoaib, Qurat-Ul-Ain organization: Department of Pharmaceutics, Akhtar Saeed College of Pharmaceutical Science Lahore, Lahore, Pakistan – sequence: 9 givenname: Sadaf surname: Aroosa fullname: Aroosa, Sadaf organization: Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences Lahore, Lahore, Pakistan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35324978$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk0uL2zAQx03Z0n2036C0gkJpD0n1sGy5h0JIX4GFLH3srQhZHjvKOpJr2aH77ask3iUueyg6SIx-8x_NaOY8OrHOQhQ9J3hKWErerV3fWlVPm2CeYpokmIpH0RnJGJ0kFLOTo_NpdO79GmPORJI8iU4ZZzTOUnEW_bqCVoPZQoFa42-QsgVqdqamM8565Eo0X14vPk5IhrZKa2PhPZoh37dbuEVq42yFKrDQqho1fV4bjYxFV-rG-E7Zp9HjUtUeng37RfTz86cf86-Ty-WXxXx2OdFpzLqJ0ErhEgsCBcdxxjMscsq4xjzhGc1iSrHAOcE4hxyAqbjUKZAszhnnWnHNLqKXB92mdl4OlfGSJjEVKUkID8TiQBROrWXTmo1qb6VTRu4Nrq2kajuja5Cl4mkhKFcJ1TFWhQCRKF5ignWZ8DgLWh-GaH2-gUKD7UL6I9HxjTUrWbmtFFmcYiGCwJtBoHW_e_Cd3Bivoa6VBdfv3x3jkDJJA_rqH_Th7AaqUiEBY0sX4uqdqJwlmSCMsgwHavoAFVYBG6NDG5Um2EcOb0cOgengT1ep3nu5-P7t_9nl9Zh9fcSuQNXdyru637fcGIwPoG6d9y2U90UmWO6m4K4acjcFcpiC4Pbi-IPune7anv0FwsYBnQ |
CitedBy_id | crossref_primary_10_3390_vaccines11071238 crossref_primary_10_7759_cureus_33139 crossref_primary_10_3390_ijerph19169779 crossref_primary_10_3390_ijerph192013692 crossref_primary_10_7759_cureus_40444 crossref_primary_10_1038_s41598_023_47863_6 crossref_primary_10_1016_j_socscimed_2022_115426 crossref_primary_10_1186_s12879_023_08029_x crossref_primary_10_1080_21645515_2023_2228164 crossref_primary_10_3389_fimmu_2023_1270187 crossref_primary_10_3390_vaccines10101733 crossref_primary_10_1177_00219096221130344 crossref_primary_10_7759_cureus_47391 crossref_primary_10_7759_cureus_33108 |
Cites_doi | 10.53685/jshmdc.v2i1.20 10.1186/1478-7954-11-16 10.1093/trstmh/traa025 10.1016/j.jinf.2020.03.059 10.1007/s13577-021-00512-4 10.1038/s41591-021-01230-y 10.1186/s12889-021-11620-z 10.1002/dmrr.3319 10.1016/S0140-6736(21)00432-3 10.3390/vaccines7020037 10.1016/j.eclinm.2020.100495 10.15585/mmwr.mm7011e2 10.1016/S2213-2600(20)30116-8 10.1016/j.vaccine.2020.08.019 10.1007/s10654-020-00670-z 10.1016/j.vaccine.2020.09.041 10.1016/j.ijid.2020.03.017 10.4269/ajtmh.20-0654 10.1038/d41573-020-00151-8 10.3390/vaccines9070757 10.1111/ajt.16480 10.1093/ije/dyt215 10.1056/NEJMoa2034577 10.2147/JMDH.S276771 10.3390/vaccines9020160 10.3390/vaccines9040349 10.7189/jogh.11.03050 10.1038/s41562-021-01056-1 10.1007/s10900-021-00993-2 10.1126/science.abc5312 10.3390/vaccines9030191 10.1080/14760584.2021.1964963 10.1016/S0140-6736(20)30566-3 10.3390/jcm10071428 10.3389/fpubh.2021.644199 10.1002/jmv.26910 10.1017/dmp.2020.329 10.3390/vaccines9020119 10.1001/jama.2020.24865 10.1056/NEJMoa2035389 10.1038/s41586-021-03696-9 10.1016/j.dsx.2020.08.032 10.1016/j.tmaid.2020.101623 10.3389/fpubh.2020.602434 10.1038/s41591-020-1124-9 10.1038/s41467-020-20226-9 10.1002/dmrr.3377 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2022 Public Library of Science 2022 Beg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 Beg et al 2022 Beg et al |
Copyright_xml | – notice: COPYRIGHT 2022 Public Library of Science – notice: 2022 Beg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 Beg et al 2022 Beg et al |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU COVID D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PIMPY PQEST PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pone.0266028 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database (ProQuest) Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest Central Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College Coronavirus Research Database ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agriculture Science Database Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Biological Science Collection ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection Coronavirus Research Database ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic Technology Collection Technology Research Database Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Agricultural Science Database CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Public Health |
DocumentTitleAlternate | Risks and perceptions of COVID-19 vaccine |
EISSN | 1932-6203 |
Editor | Siddiqi, Tariq Jamal |
Editor_xml | – sequence: 1 givenname: Tariq Jamal surname: Siddiqi fullname: Siddiqi, Tariq Jamal |
EndPage | e0266028 |
ExternalDocumentID | 2642871615 oai_doaj_org_article_fa57d825a62c40ad8e86a5f010cf6549 A698132390 10_1371_journal_pone_0266028 35324978 |
Genre | Journal Article |
GeographicLocations | Pakistan United States--US Lahore Pakistan |
GeographicLocations_xml | – name: Pakistan – name: Lahore Pakistan – name: United States--US |
GroupedDBID | --- 123 29O 2WC 3V. 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BBORY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CGR CS3 CUY CVF D1I D1J D1K DIK DU5 E3Z EAP EAS EBD ECM EIF EMOBN ESTFP ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IHR IHW INH INR IOV IPNFZ IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ NPM O5R O5S OK1 P2P P62 PATMY PDBOC PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RIG RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM AAYXX AFPKN CITATION 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K COVID DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PQEST PQUKI PRINS RC3 7X8 5PM AAPBV ABPTK N95 |
ID | FETCH-LOGICAL-c743t-8caa0f081ed50495908b235c0565929422080b100bebee3a4fc7e194b355ca5c3 |
IEDL.DBID | RPM |
ISSN | 1932-6203 |
IngestDate | Sun Jul 02 11:03:49 EDT 2023 Tue Oct 22 14:58:26 EDT 2024 Tue Sep 17 21:06:57 EDT 2024 Sat Oct 26 00:02:22 EDT 2024 Thu Oct 10 22:19:17 EDT 2024 Tue Nov 19 21:11:13 EST 2024 Tue Nov 12 22:53:22 EST 2024 Thu Aug 01 20:30:25 EDT 2024 Thu Aug 01 20:29:00 EDT 2024 Tue Aug 20 22:07:10 EDT 2024 Fri Aug 23 04:08:33 EDT 2024 Wed Oct 16 00:41:49 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c743t-8caa0f081ed50495908b235c0565929422080b100bebee3a4fc7e194b355ca5c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Competing Interests: The authors have declared that no competing interests exist. |
ORCID | 0000-0001-6797-4879 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947088/ |
PMID | 35324978 |
PQID | 2642871615 |
PQPubID | 1436336 |
PageCount | e0266028 |
ParticipantIDs | plos_journals_2642871615 doaj_primary_oai_doaj_org_article_fa57d825a62c40ad8e86a5f010cf6549 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8947088 proquest_miscellaneous_2644008017 proquest_journals_2642871615 gale_infotracmisc_A698132390 gale_infotracacademiconefile_A698132390 gale_incontextgauss_ISR_A698132390 gale_incontextgauss_IOV_A698132390 gale_healthsolutions_A698132390 crossref_primary_10_1371_journal_pone_0266028 pubmed_primary_35324978 |
PublicationCentury | 2000 |
PublicationDate | 2022-03-24 |
PublicationDateYYYYMMDD | 2022-03-24 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-24 day: 24 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2022 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | J Murphy (pone.0266028.ref038) 2021; 12 N. Pakistan (pone.0266028.ref061) 2020 AJ Rodriguez-Morales (pone.0266028.ref053) 2020; 34 W Guo (pone.0266028.ref051) 2020; 36 AK Singh (pone.0266028.ref048) 2020; 14 SI Gilani (pone.0266028.ref056) 2013; 11 HP i Arolas (pone.0266028.ref003) 2021; 11 Y Zhou (pone.0266028.ref050) 2021; 37 Prevention Control CfD (pone.0266028.ref039) 2020 SH Woolf (pone.0266028.ref001) 2021; 325 YH Khan (pone.0266028.ref032) 2020; 103 M Zuin (pone.0266028.ref047) 2020; 81 Q Jin (pone.0266028.ref020) 2021; 9 P Lloyd-Sherlock (pone.0266028.ref049) 2014; 43 Z Wang (pone.0266028.ref042) 2021; 595 M Detoc (pone.0266028.ref043) 2020; 38 AG Mathioudakis (pone.0266028.ref059) 2021; 11 A Karlinsky (pone.0266028.ref002) 2021 LR Baden (pone.0266028.ref010) 2021; 384 R Shekhar (pone.0266028.ref037) 2021; 9 F Al Hosany (pone.0266028.ref015) 2021; 11 A Riad (pone.0266028.ref029) 2021; 10 R Jayadevan (pone.0266028.ref058) 2021 L Fang (pone.0266028.ref052) 2020; 8 S Loomba (pone.0266028.ref018) 2021; 5 WJ Guan (pone.0266028.ref046) 2020; 55 L Corey (pone.0266028.ref024) 2020; 368 JL Kriss (pone.0266028.ref040) 2021; 70 B Qubais (pone.0266028.ref060) 2021 SM Saied (pone.0266028.ref028) 2021; 93 TT Le (pone.0266028.ref008) 2020; 19 J. Anesi (pone.0266028.ref025) 2021; 21 MA Liu (pone.0266028.ref012) 2019; 7 A Majeed (pone.0266028.ref005) 2021 A Malik (pone.0266028.ref017) 2021 Y Yang (pone.0266028.ref057) 2021; 46 E. Dolgin (pone.0266028.ref041) 2021 S. Saleem (pone.0266028.ref033) 2021; 2 Y Yan (pone.0266028.ref031) 2021; 9 M Ahmad (pone.0266028.ref004) 2021; 9 M. Sallam (pone.0266028.ref026) 2021; 9 M Voysey (pone.0266028.ref006) 2021; 397 G. Iacobellis (pone.0266028.ref054) 2020 I Ali (pone.0266028.ref021) 2020 M Al-Mohaithef (pone.0266028.ref035) 2020; 13 J Wang (pone.0266028.ref013) 2021; 9 JH Kim (pone.0266028.ref014) 2021; 27 J Yang (pone.0266028.ref044) 2020; 94 J. Whitworth (pone.0266028.ref007) 2020; 114 SC Quinn (pone.0266028.ref011) 2020 MS Islam (pone.0266028.ref062) 2021 S Barello (pone.0266028.ref027) 2020; 35 F Ahamed (pone.0266028.ref023) 2021; 21 JV Lazarus (pone.0266028.ref034) 2021; 27 S Mahmood (pone.0266028.ref019) 2020; 8 S Kashte (pone.0266028.ref016) 2021; 34 S Alan (pone.0266028.ref055) 1998; 48 S Chandir (pone.0266028.ref022) 2020; 38 FP Polack (pone.0266028.ref009) 2020; 383 F Zhou (pone.0266028.ref045) 2020; 395 TF Ahmed (pone.0266028.ref030) 2021; 20 AA Malik (pone.0266028.ref036) 2020; 26 |
References_xml | – volume: 2 start-page: 6 issue: 1 year: 2021 ident: pone.0266028.ref033 article-title: COVID-19 Vaccine Uptake in Pakistan: No Time to Err. publication-title: Journal of Shalamar Medical & Dental College-JSHMDC doi: 10.53685/jshmdc.v2i1.20 contributor: fullname: S. Saleem – volume: 11 start-page: 1 issue: 1 year: 2013 ident: pone.0266028.ref056 article-title: Prevalence and sociodemographic determinants of tobacco use among adults in Pakistan: findings of a nationwide survey conducted in 2012 publication-title: Population health metrics. doi: 10.1186/1478-7954-11-16 contributor: fullname: SI Gilani – volume: 114 start-page: 241 issue: 4 year: 2020 ident: pone.0266028.ref007 article-title: COVID-19: a fast evolving pandemic publication-title: Trans R Soc Trop Med Hyg doi: 10.1093/trstmh/traa025 contributor: fullname: J. Whitworth – volume: 55 issue: 5 year: 2020 ident: pone.0266028.ref046 article-title: Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis publication-title: Eur Respir J contributor: fullname: WJ Guan – volume: 81 start-page: e84 issue: 1 year: 2020 ident: pone.0266028.ref047 article-title: Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis publication-title: J Infect doi: 10.1016/j.jinf.2020.03.059 contributor: fullname: M Zuin – volume: 34 start-page: 711 issue: 3 year: 2021 ident: pone.0266028.ref016 article-title: COVID-19 vaccines: rapid development, implications, challenges and future prospects publication-title: Hum Cell doi: 10.1007/s13577-021-00512-4 contributor: fullname: S Kashte – volume: 27 start-page: 205 issue: 2 year: 2021 ident: pone.0266028.ref014 article-title: Looking beyond COVID-19 vaccine phase 3 trials publication-title: Nat Med doi: 10.1038/s41591-021-01230-y contributor: fullname: JH Kim – volume: 21 start-page: 1 issue: 1 year: 2021 ident: pone.0266028.ref023 article-title: Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID–19 in the UAE publication-title: BMC public health doi: 10.1186/s12889-021-11620-z contributor: fullname: F Ahamed – volume: 36 start-page: e3319 issue: 7 year: 2020 ident: pone.0266028.ref051 article-title: Diabetes is a risk factor for the progression and prognosis of COVID‐19 publication-title: Diabetes/metabolism research and reviews doi: 10.1002/dmrr.3319 contributor: fullname: W Guo – volume: 397 start-page: 881 issue: 10277 year: 2021 ident: pone.0266028.ref006 article-title: Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(21)00432-3 contributor: fullname: M Voysey – year: 2021 ident: pone.0266028.ref060 article-title: Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination publication-title: medRxiv contributor: fullname: B Qubais – volume: 7 start-page: 37 issue: 2 year: 2019 ident: pone.0266028.ref012 article-title: A comparison of plasmid DNA and mRNA as vaccine technologies publication-title: Vaccines doi: 10.3390/vaccines7020037 contributor: fullname: MA Liu – volume: 26 start-page: 100495 year: 2020 ident: pone.0266028.ref036 article-title: Determinants of COVID-19 vaccine acceptance in the US publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2020.100495 contributor: fullname: AA Malik – volume: 70 start-page: 389 issue: 11 year: 2021 ident: pone.0266028.ref040 article-title: COVID-19 vaccine second-dose completion and interval between first and second doses among vaccinated persons—United States, December 14, 2020− February 14, 2021 publication-title: Morbidity and Mortality Weekly Report doi: 10.15585/mmwr.mm7011e2 contributor: fullname: JL Kriss – volume: 8 start-page: e21 issue: 4 year: 2020 ident: pone.0266028.ref052 article-title: Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? publication-title: The lancet respiratory medicine doi: 10.1016/S2213-2600(20)30116-8 contributor: fullname: L Fang – year: 2021 ident: pone.0266028.ref058 article-title: Survey of symptoms following COVID-19 vaccination in India. publication-title: medRxiv contributor: fullname: R Jayadevan – year: 2021 ident: pone.0266028.ref017 article-title: Acceptance of COVID-19 vaccine in Pakistan among health care workers publication-title: medRxiv contributor: fullname: A Malik – volume: 38 start-page: 7146 issue: 45 year: 2020 ident: pone.0266028.ref022 article-title: Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: an analysis of provincial electronic immunization registry data publication-title: Vaccine doi: 10.1016/j.vaccine.2020.08.019 contributor: fullname: S Chandir – volume: 35 start-page: 781 issue: 8 year: 2020 ident: pone.0266028.ref027 article-title: ‘Vaccine hesitancy’among university students in Italy during the COVID-19 pandemic. publication-title: European journal of epidemiology doi: 10.1007/s10654-020-00670-z contributor: fullname: S Barello – volume: 38 start-page: 7002 issue: 45 year: 2020 ident: pone.0266028.ref043 article-title: Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic publication-title: Vaccine doi: 10.1016/j.vaccine.2020.09.041 contributor: fullname: M Detoc – volume: 94 start-page: 91 year: 2020 ident: pone.0266028.ref044 article-title: Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.03.017 contributor: fullname: J Yang – volume: 103 start-page: 603 issue: 2 year: 2020 ident: pone.0266028.ref032 article-title: Threat of COVID-19 Vaccine Hesitancy in Pakistan: The Need for Measures to Neutralize Misleading Narratives publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.20-0654 contributor: fullname: YH Khan – volume: 19 start-page: 667 issue: 10 year: 2020 ident: pone.0266028.ref008 article-title: Evolution of the COVID-19 vaccine development landscape publication-title: Nat Rev Drug Discov doi: 10.1038/d41573-020-00151-8 contributor: fullname: TT Le – year: 2020 ident: pone.0266028.ref011 article-title: Communicating effectively about emergency use authorization and vaccines in the COVID-19 pandemic publication-title: American Public Health Association contributor: fullname: SC Quinn – volume: 9 start-page: 757 issue: 7 year: 2021 ident: pone.0266028.ref020 article-title: Can communication strategies combat COVID-19 vaccine hesitancy with trade-off between public service messages and public skepticism? Experimental evidence from Pakistan publication-title: Vaccines doi: 10.3390/vaccines9070757 contributor: fullname: Q Jin – volume: 21 start-page: 897 issue: 2 year: 2021 ident: pone.0266028.ref025 article-title: The advisory Committee on Immunization practices’ updated interim recommendation for allocation of COVID‐19 vaccine—United states, December 2020. publication-title: American Journal of Transplantation doi: 10.1111/ajt.16480 contributor: fullname: J. Anesi – volume: 43 start-page: 116 issue: 1 year: 2014 ident: pone.0266028.ref049 article-title: Hypertension among older adults in low-and middle-income countries: prevalence, awareness and control publication-title: International journal of epidemiology doi: 10.1093/ije/dyt215 contributor: fullname: P Lloyd-Sherlock – year: 2021 ident: pone.0266028.ref062 article-title: Knowledge, attitudes and perceptions towards COVID-19 vaccinations: a cross-sectional community survey in Bangladesh publication-title: medRxiv contributor: fullname: MS Islam – start-page: 162 year: 2020 ident: pone.0266028.ref054 article-title: COVID-19 and diabetes: can DPP4 inhibition play a role? publication-title: Diabetes research and clinical practice contributor: fullname: G. Iacobellis – volume: 383 start-page: 2603 issue: 27 year: 2020 ident: pone.0266028.ref009 article-title: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine publication-title: N Engl J Med doi: 10.1056/NEJMoa2034577 contributor: fullname: FP Polack – volume: 13 start-page: 1657 year: 2020 ident: pone.0266028.ref035 article-title: Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey. publication-title: J Multidiscip Healthc doi: 10.2147/JMDH.S276771 contributor: fullname: M Al-Mohaithef – volume: 9 start-page: 160 issue: 2 year: 2021 ident: pone.0266028.ref026 article-title: COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. publication-title: Vaccines (Basel). doi: 10.3390/vaccines9020160 contributor: fullname: M. Sallam – start-page: 56 year: 2021 ident: pone.0266028.ref005 article-title: Evaluation of immunomodulatory effects of lomefloxacin in mice publication-title: Brazilian Journal of Pharmaceutical Sciences contributor: fullname: A Majeed – volume: 9 start-page: 349 issue: 4 year: 2021 ident: pone.0266028.ref031 article-title: The COVID-19 Vaccines: Recent Development, Challenges and Prospects publication-title: Vaccines (Basel). doi: 10.3390/vaccines9040349 contributor: fullname: Y Yan – volume: 11 start-page: 03050 year: 2021 ident: pone.0266028.ref015 article-title: Response to COVID-19 pandemic in the UAE: A public health perspective. publication-title: J Glob Health doi: 10.7189/jogh.11.03050 contributor: fullname: F Al Hosany – year: 2021 ident: pone.0266028.ref041 article-title: Is one vaccine dose enough if you’ve had COVID? What the science says publication-title: Nature Publishing Group contributor: fullname: E. Dolgin – volume: 11 start-page: 249 issue: 3 year: 2021 ident: pone.0266028.ref059 article-title: Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey. publication-title: Life (Basel). contributor: fullname: AG Mathioudakis – volume: 5 start-page: 337 issue: 3 year: 2021 ident: pone.0266028.ref018 article-title: Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the publication-title: UK and USA. Nature human behaviour doi: 10.1038/s41562-021-01056-1 contributor: fullname: S Loomba – volume: 46 start-page: 1090 issue: 6 year: 2021 ident: pone.0266028.ref057 article-title: COVID-19 vaccine hesitancy and its determinants among adults with a history of tobacco or marijuana use publication-title: Journal of community health doi: 10.1007/s10900-021-00993-2 contributor: fullname: Y Yang – volume: 11 start-page: 1 issue: 1 year: 2021 ident: pone.0266028.ref003 article-title: Years of life lost to COVID-19 in 81 countries publication-title: Scientific reports contributor: fullname: HP i Arolas – volume: 368 start-page: 948 issue: 6494 year: 2020 ident: pone.0266028.ref024 article-title: A strategic approach to COVID-19 vaccine R&D publication-title: Science doi: 10.1126/science.abc5312 contributor: fullname: L Corey – year: 2021 ident: pone.0266028.ref002 article-title: The World Mortality Dataset: Tracking excess mortality across countries during the COVID-19 pandemic publication-title: medRxiv contributor: fullname: A Karlinsky – volume: 9 start-page: 191 issue: 3 year: 2021 ident: pone.0266028.ref013 article-title: The Changing Acceptance of COVID-19 Vaccination in Different Epidemic Phases in China: A Longitudinal Study. publication-title: Vaccines (Basel). doi: 10.3390/vaccines9030191 contributor: fullname: J Wang – volume: 20 start-page: 1185 issue: 9 year: 2021 ident: pone.0266028.ref030 article-title: Understanding COVID-19 vaccine acceptance in Pakistan: an echo of previous immunizations or prospect of change? publication-title: Expert Review of Vaccines doi: 10.1080/14760584.2021.1964963 contributor: fullname: TF Ahmed – volume: 395 start-page: 1054 issue: 10229 year: 2020 ident: pone.0266028.ref045 article-title: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)30566-3 contributor: fullname: F Zhou – volume: 48 start-page: 64 year: 1998 ident: pone.0266028.ref055 article-title: Prevalence and pattern of smoking in Pakistan. publication-title: JOURNAL-PAKISTAN MEDICAL ASSOCIATION contributor: fullname: S Alan – volume: 10 start-page: 1428 issue: 7 year: 2021 ident: pone.0266028.ref029 article-title: Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. publication-title: Journal of clinical medicine doi: 10.3390/jcm10071428 contributor: fullname: A Riad – volume: 9 start-page: 644199 year: 2021 ident: pone.0266028.ref004 article-title: Epidemiological and Clinical Characteristics of COVID-19: A Retrospective Multi-Center Study in Pakistan publication-title: Front Public Health doi: 10.3389/fpubh.2021.644199 contributor: fullname: M Ahmad – volume: 93 start-page: 4280 issue: 7 year: 2021 ident: pone.0266028.ref028 article-title: Abdo SAEF. Vaccine hesitancy: Beliefs and barriers associated with COVID‐19 vaccination among Egyptian medical students publication-title: Journal of medical virology doi: 10.1002/jmv.26910 contributor: fullname: SM Saied – start-page: 1 year: 2020 ident: pone.0266028.ref021 article-title: Why may COVID-19 overwhelm low-income countries like Pakistan? publication-title: Disaster Medicine and Public Health Preparedness doi: 10.1017/dmp.2020.329 contributor: fullname: I Ali – year: 2020 ident: pone.0266028.ref061 publication-title: COVID-19 Health Advisory Platform by Ministry of National Health Services Regulations and Coordination contributor: fullname: N. Pakistan – volume: 9 start-page: 119 issue: 2 year: 2021 ident: pone.0266028.ref037 article-title: COVID-19 vaccine acceptance among health care workers in the United States publication-title: Vaccines doi: 10.3390/vaccines9020119 contributor: fullname: R Shekhar – volume: 325 start-page: 123 issue: 2 year: 2021 ident: pone.0266028.ref001 article-title: COVID-19 as the leading cause of death in the United States publication-title: Jama doi: 10.1001/jama.2020.24865 contributor: fullname: SH Woolf – volume: 384 start-page: 403 issue: 5 year: 2021 ident: pone.0266028.ref010 article-title: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine publication-title: N Engl J Med doi: 10.1056/NEJMoa2035389 contributor: fullname: LR Baden – volume: 595 start-page: 426 issue: 7867 year: 2021 ident: pone.0266028.ref042 article-title: Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection publication-title: Nature doi: 10.1038/s41586-021-03696-9 contributor: fullname: Z Wang – volume: 14 start-page: 1625 issue: 6 year: 2020 ident: pone.0266028.ref048 article-title: Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India publication-title: Diabetes Metab Syndr doi: 10.1016/j.dsx.2020.08.032 contributor: fullname: AK Singh – year: 2020 ident: pone.0266028.ref039 article-title: How CDC is making COVID-19 vaccine recommendations publication-title: December contributor: fullname: Prevention Control CfD – volume: 34 start-page: 101623 year: 2020 ident: pone.0266028.ref053 article-title: Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis publication-title: Travel Med Infect Dis doi: 10.1016/j.tmaid.2020.101623 contributor: fullname: AJ Rodriguez-Morales – volume: 8 start-page: 861 year: 2020 ident: pone.0266028.ref019 article-title: Attitude, Perception, and Knowledge of COVID-19 Among General Public in Pakistan. publication-title: Frontiers in Public Health doi: 10.3389/fpubh.2020.602434 contributor: fullname: S Mahmood – volume: 27 start-page: 225 issue: 2 year: 2021 ident: pone.0266028.ref034 article-title: A global survey of potential acceptance of a COVID-19 vaccine publication-title: Nature medicine doi: 10.1038/s41591-020-1124-9 contributor: fullname: JV Lazarus – volume: 12 start-page: 29 issue: 1 year: 2021 ident: pone.0266028.ref038 article-title: Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. publication-title: Nat Commun doi: 10.1038/s41467-020-20226-9 contributor: fullname: J Murphy – volume: 37 start-page: e3377 issue: 2 year: 2021 ident: pone.0266028.ref050 article-title: Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19). publication-title: Diabetes/Metabolism Research and Reviews doi: 10.1002/dmrr.3377 contributor: fullname: Y Zhou |
SSID | ssj0053866 |
Score | 2.5120234 |
Snippet | The coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines may offer a... Background The coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines... Background The coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines... BACKGROUNDThe coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines... BackgroundThe coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines... |
SourceID | plos doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e0266028 |
SubjectTerms | Adult Aged Asthenia Attitudes Biology and Life Sciences Coronaviruses COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 Vaccines Cross-Sectional Studies Demographics Demography Diabetes Evaluation Female Global health Health behavior Humans Male Medicine and Health Sciences Middle Aged Mortality Muscles Pain Pakistan - epidemiology Pandemics People and Places Perception Perceptions Polls & surveys Public health Questionnaires Risk perception SARS-CoV-2 Signs and symptoms Social networks Surveys and Questionnaires Vaccination Vaccines Viral diseases |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZgT1wQ5dXtAwxCAg5p8_Ar3JY-1F4oolBxQZbj2KUSSlZNU4l_z0zsDQ2qBAeu69lod2Zsf58y8w0hr2TmixJwdZKZWiBBMUnFZZE4yWxV5cylFvudj07lh69q_wBlcsZRX1gTFuSBg-N2veGyBhpjRG5ZamrllDDcA42wXgC5GU7fVK3IVDiDYRcLERvlCpntxrjsLNvG7QDrEClOX79xEQ16_eOpPFv-aLvbIOeflZM3rqLDB-R-xJB0EX77GrnjmodkLe7Sjr6JUtJvH5FvH7FuBQ60mmINOTVNTZe_S1lo6-neydnxfpKV9NpYfMn-ji5o119eu590GEREz8PTaBDEphcNjaizeUy-HB583jtK4kCFxAJQuEqUNSb1AAJczYEZ4LjzKi-4BRDEASaxPAf8WGVpWkFoXWGYt9JlJasAlFjDbfGEzBpw4TqhQmW2NK6qrBOs9E4ppiz33lgBnKio5yRZeVcvg26GHl6eSeAbwU0ao6FjNObkPYZgtEXV6-EDyAUdc0H_LRfm5DkGUIcW0nHv6oUoFbDuokzn5OVggcoXDZbWnJu-6_Txydk_GJ1-mhi9jka-hVSwJrYzwH9CRa2J5dbEEvavnSyvY7qtvNLpXAQam3H45ioFb19-MS7jQ7FcrnFtP9gw5AKZnJOnIWNHzxYcMHQpweNykssT109Xmovvg_C4KpmEW2njf8Rqk9zLsZMkLZKcbZHZ1WXvtsndru6fDVv5F7eqTGc priority: 102 providerName: Directory of Open Access Journals |
Title | Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35324978 https://www.proquest.com/docview/2642871615 https://search.proquest.com/docview/2644008017 https://pubmed.ncbi.nlm.nih.gov/PMC8947088 https://doaj.org/article/fa57d825a62c40ad8e86a5f010cf6549 http://dx.doi.org/10.1371/journal.pone.0266028 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbYPaBeEOXVQCkGIQGH7ObhR8Jt2bZqD9CKQsUFRY5jb1dqk2jTVOLfM3ac0KAeENd4EiXzsL8vnhkj9JaHOk4BV_uhKJghKMLPKY99xYnM84ioQJp656Mz_uVHsn9g2uTQvhbGJu3LfD0rL69m5frC5lbWV3Le54nNTz8vk5RwiI75BE0AG_YUvZt-IYAZczVyMQ_nziSzuirVDAgHgwV1C92PKSAJe7jareXIdu0f5uZpfVk1dwHPv_Mnby1Ihw_RA4ck8aJ74210T5WP0LaL1Qa_dw2lPzxGP09N9gpMawU2meRYlAWu_yS04Erj5cn58b4fpvhGSLPV_hEvcNNubtQvbI8jwqvuabhri43XJXbYs3yCvh8efFse-e5YBV8CXLj2EylEoAEKqIICPzCHnudRTCVAIQpgiUQRoMg8DIIcDKxiQbTkKkxJDtBECirjp2hagjZ3EGZJKFOh8lwqRlKtkoQkkmotJANmFBce8nvtZnXXPSOzW2gcWEenpswYJnOG8dAnY4JB1vS-theqzSpzHpBpQXkBxFawSJJAFIlKmKAaiKXUDOiuh14ZA2ZdIekQwdmCpQlw7zgNPPTGSpj-F6VJsFmJtmmy45PzfxA6-zoSeueEdAWuIIUraoBvMn21RpK7I0mIYjka3jHu1mulySLWkdmQwp29C949_HoYNg81SXOlqlorQwwjCLmHnnUeO2i2938P8ZEvj1Q_HoFotO3HXfQ9_-87X6CtyBSRBLEfkV00vd606iWaNEW7Z3-J7NmA_g1Ld03b |
link.rule.ids | 230,315,729,782,786,866,887,2108,27935,27936,53803,53805 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELboIkEvQHk1UKhBSMAhu0n8Srgt21a7oi_Rh7igyHHsZaU2WW26lfj3jBNnaVAPqNfMOFLmYX-fMjNG6IMIDUkAV_uhzLklKNLPmCC-FlRlWUR1oGy_8_hEHP6Id3btmBzW9sLURfsqm_WLi8t-MftV11bOL9WgrRMbHB-M4oQKyI7BGroP-RqQlqQ3GzA84tx1yRERDpxT-vOy0H2gHByO1HX0gDDAEvX1ajcOpHpu_2p37s0vyuo26PlvBeWNI2nv8R0_5gl65DAoHjbiDXRPF0_RhsvyCn9yo6g_P0M_j23dC2yIObY16FgWOZ7_LYXBpcGjo_PJjh8m-Foq-5P-Cx7iarm41r9xfZERnjZvw81AbTwrsEOtxXN0trd7Ohr77kIGXwHQuPJjJWVgAETonAGzsNelZxFhCkAUA5hFowjwZxYGQQahoYmkRgkdJjQDUKMkU-QF6hXghU2EeRyqROosU5rTxOg4prFixkjFgVOR3EN-65V03szdSOufbwL4SmOm1Do0dQ710FfrupWunZpdPygX09SZOzWSiRwoseSRooHMYx1zyQxQUmU4EGUPbVvHp00L6ir30yFPYmDtJAk89L7WsJMzCluaM5XLqkonR-f_oXTyvaP00SmZEkJISdcOAd9kJ3J1NLc6mpD_qiPetGHaWqVKI97Q4JDByjZ0bxe_W4ntS225XaHLZa1DLZcIhYdeNpG-smybNx4SnRzomL4rgdCvB5e7UH9155Xb6OH49GA_3Z8cfnuN1iPbihIQP6JbqHe1WOo3aK3Kl2_r7eAPIeNifQ |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLZYkaa9AOO2wGAGIQEPaXOxnYS30q5aBWwVg4kXFDmOXSptSdSsk_j3HDtOWNAeELzGx5Hic_H3KeeC0KvIV2ECuNr1ec40QeFuRqPQlRERWRYQ6Qld73x0Gh1_i6eHuk1ON-rLJO2LbDUszi-GxeqHya2sLsSozRMbLT5N4oRE4B2jKlejLXQbfNajLVFvgjA8YsxWyoWRP7KKGVZlIYdAOxhcqztoO6SAJ8yItWuXkund30XoQXVe1jfBzz-zKK9dS7O7__FB99Adi0XxuBHZRbdkcR_tWm-v8RvbkvrtA_R9ofNfIDDmWOeiY17kuPqdEoNLhScnZ_Op6yf4igv9s_4dHuN6s76SP7EZaISXzdtw01gbrwps0WvxEH2dHX6ZHLl2MIMrAHBcurHg3FMAJmROgWHoselZEFIBYIoC3CJBADg08z0vAxORISdKRNJPSAbgRnAqwkdoUIAm9hBmsS8SLrNMSEYSJeOYxIIqxQUDbhXmDnJbzaRV038jNT_hIuAtzTGlWqmpVaqD3mv1dbK6e7Z5UK6XqT3yVHEa5UCNOQsE8Xgey5hxqoCaCsWAMDvoQCs_bUpRuxiQjlkSA3sPE89BL42E7qBR6BSdJd_UdTo_OfsLodPPPaHXVkiVYEaC27II-Cbdmasnud-ThDggest72lTbU6nTgDV02KewszXfm5dfdMv6pTrtrpDlxsgQzSn8yEGPG2vvTrb1HQdFPT_oHX1_BczfNDC35v7kn3ceoO3FdJZ-nB9_eIp2Al2R4oVuQPbR4HK9kc_QVp1vnpuI8Asx-WT9 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Perceived+risk+and+perceptions+of+COVID-19+vaccine%3A+A+survey+among+general+public+in+Pakistan&rft.jtitle=PloS+one&rft.au=Beg%2C+Bilal+Mahmood&rft.au=Hussain%2C+Tariq&rft.au=Ahmad%2C+Mehmood&rft.au=Areej%2C+Sadaf&rft.date=2022-03-24&rft.eissn=1932-6203&rft.volume=17&rft.issue=3&rft.spage=e0266028&rft.epage=e0266028&rft_id=info:doi/10.1371%2Fjournal.pone.0266028&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |